Trends in HPV‐associated cancer incidence in Texas medically underserved regions
Cancer Medicine · 2024
DOI: 10.1002/cam4.70133 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Thao N Hoang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Translational Sciences, University of Texas Medical Branch, Galveston, Texas, USA. Hauptthemen laut MEDLINE: Medically Underserved Area, Papillomavirus Infections. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, Cancer Prevention and Research Institute of Texas, NIAMS NIH HHS.
Abstract (Originalsprache)
Background
While cervical cancer incidence rates (IR) in the United States have dropped in the last 20 years, non‐cervical human papillomavirus (HPV) associated cancers increased. Many people in Texas (TX) live in medically underserved areas and have higher risk of developing HPV‐associated cancers. Since previous studies of these regions focused on cervical cancer, we included other HPV‐associated cancers in our analysis of IR in East TX and the TX‐Mexico Border compared to other TX regions.
Methods
Cancer data from 2006 to 2019 were obtained from the TX Cancer Registry. Cases of HPV‐associated cervical, vaginal, vulvar, penile, anal, and oropharyngeal cancers and corresponding patient‐level demographic data were included. We calculated IR per 100,000 and drew heat maps to visualize cancer IR by county. To control potential confounders, we added county‐level risk factors: rates for smoking, excessive drinking, obesity, STIs, primary care provider availability and dentist availability, from the County Health Rankings and Roadmaps program. We reported IRs by region and time and estimated unadjusted and adjusted risk ratio (RR) for association of each type of cancer and region. Lastly, we created adjusted models for each cancer by period to see time trends of regional differences.
Results
Risk of anal, cervical, and oropharyngeal cancer was lower at parts of the Border than in the rest of TX in the adjusted model. We also observed increasing anal and oropharyngeal cancer risk and decreasing cervical and vaginal cancer risk over time.
Conclusion
Patient sociodemographics, behavioral risk factors, and access to care may contribute to some observed differences in cancer IR across regions. This indicates that targeted prevention efforts towards these regions, especially in low socioeconomic status communities, may benefit future generations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute for Translational Sciences, University of Texas Medical Branch, Galveston, Texas, USA.
- Center for Interdisciplinary Research in Women's Health, University of Texas Medical Branch, Galveston, Texas, USA.
- Department of Obstetrics and Gynecology, The University of Texas Medical Branch at Galveston, Galveston, Texas, USA.
- Department of Biostatistics and Data Science, University of Texas Medical Branch, Galveston, Texas, USA.
ORCID-Profile: Thao N Hoang, Abbey B Berenson, Fangjian Guo
Förderung
- NIH HHS
- Cancer Prevention and Research Institute of Texas
- NIAMS NIH HHS
- AHRQ HHS
- Agency for Healthcare Research and Quality
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- National Institutes of Health
Zitieren
APA
Hoang, T. N., Berenson, A. B., Shan, Y., Guo, F., Adekanmbi, V., Hsu, C., Yu, X., & Kuo, Y. F. (2024). Trends in HPV‐associated cancer incidence in Texas medically underserved regions. Cancer Medicine. https://doi.org/10.1002/cam4.70133
Vancouver
Hoang TN, Berenson AB, Shan Y, Guo F, Adekanmbi V, Hsu C, et al. Trends in HPV‐associated cancer incidence in Texas medically underserved regions. Cancer Medicine. 2024. doi:10.1002/cam4.70133
BibTeX
@article{Hoang2024,
author = {Hoang, Thao N and Berenson, Abbey B and Shan, Yong and Guo, Fangjian and Adekanmbi, Victor and Hsu, Christine and Yu, Xiaoying and Kuo, Yong-Fang},
title = {Trends in HPV‐associated cancer incidence in Texas medically underserved regions},
journal = {Cancer Medicine},
year = {2024},
doi = {10.1002/cam4.70133}
}
EUVIMED